Tasly Pharmaceutical schedules Q3 2025 earnings briefing for December 4

Tasly Pharmaceutical Group Co., Ltd. will host its 2025 third-quarter earnings briefing on December 4, 2025, from 3:00 PM to 4:00 PM. The online interactive session will be held via the Shanghai Stock Exchange Roadshow Center (https://roadshow.sseinfo.com/) to discuss the company's third-quarter operating results and financial condition, which were released on October 25, 2025.

Shareholders can submit questions in advance from November 27 to December 3, 2025, at 4:00 PM by logging into the "Question Submission" section on the SSE Roadshow Center website or by emailing stock@tasly.com. The company's management will address widely watched investor concerns during the briefing.

Key participants from Tasly Pharmaceutical will include Mr. Cai Jinyong, director and general manager; Mr. Yu Jie, board secretary; Ms. Wei Jie, chief financial officer; and Ms. Han Xiutao, independent director.